Ceramides and mitochondrial fatty acid oxidation in obesity.

Ceramides and mitochondrial fatty acid oxidation in obesity.

Item
http://www.wikidata.org/entity/Q30239998
The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease.Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity.Dietary Fatty Acids Alter Lipid Profiles and Induce Myocardial Dysfunction without Causing Metabolic Disorders in Mice.Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer.Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome.The Effect of Lean-Seafood and Non-Seafood Diets on Fasting and Postprandial Serum Metabolites and Lipid Species: Results from a Randomized Crossover Intervention Study in Healthy Adults.GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation
P2860

Ceramides and mitochondrial fatty acid oxidation in obesity.

Item
http://www.wikidata.org/entity/Q30239998
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Ceramides and mitochondrial fatty acid oxidation in obesity.
@ast
Ceramides and mitochondrial fatty acid oxidation in obesity.
@en
type
label
Ceramides and mitochondrial fatty acid oxidation in obesity.
@ast
Ceramides and mitochondrial fatty acid oxidation in obesity.
@en
prefLabel
Ceramides and mitochondrial fatty acid oxidation in obesity.
@ast
Ceramides and mitochondrial fatty acid oxidation in obesity.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Ceramides and mitochondrial fatty acid oxidation in obesity
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921